The British government’s plan for a landmark smoking ban that aims to stop young people from ever smoking cleared its first hurdle in Parliament on Tuesday.

President Joe Biden's administration will help 50 countries to identify and respond to infectious diseases.

A majority of Americans say they would feel better if they could have more sleep, according to a new Gallup poll.

The Supreme Court will permit Idaho to enforce its ban on gender-affirming care for transgender youth while lawsuits on the matter proceed.

European Medicines Agency found no evidence that diabetes and weight-loss drugs such as Ozempic and Wegovy are linked to higher risk of suicidal thought or action.

A Houston hospital has halted its liver and kidney transplant programs after learning a doctor manipulated records for liver transplant candidates, according to a media report.

Polish lawmakers voted Friday to continue work on a bill package that is intended to ease a near-total ban on abortion services in that country.

A rise in measles cases have raised concern about the virus.

A federal appeals court will hear arguments Thursday on Arkansas' first-in-the-nation ban on gender-affirming care such as hormone treatment or puberty blockers for minors.

The Biden administration on Wednesday issued the first limits on certain so-called “forever chemicals” in drinking water that will require utilities to monitor and if necessary, take treatment steps.

More than 200 chemical plants nationwide will be required to reduce toxic emissions that are likely to cause cancer under a new rule issued Tuesday by the Environmental Protection Agency.

The Supplemental Nutrition Program for Women, Infants and Children, known as WIC, will soon allow more options such as lactose-free milk and additional whole grain options for its client vouchers.

The Arizona Supreme Court ruled Tuesday that the state can enforce a long-dormant law criminalizing all abortions, except when a mother’s life is at stake.

U.S. Food and Drug Administration’s accelerated approval program is intended to give patients early access to promising drugs. But how often do these drugs improve or extend a patient’s life?

Johnson & Johnson is pumping more money into heart care with a $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.